Previous 10 | Next 10 |
2024-03-21 08:18:31 ET Summary Elevance Health is a provider of health plans and pharmacy benefits management. The company has shown strong revenue growth, particularly in its Healthcare segment and CarelonRx. Earnings per share and operating margin have been inconsistent, but...
2024-03-20 22:08:42 ET Summary Ruane, Cunniff & Goldfarb's 13F portfolio value increased to $6.26B with 33 holdings. Top three positions are Intercontinental Exchange, Alphabet, and Charles Schwab. Sequoia Fund, managed by the firm, had a bad year in 2022 but outperformed ...
2024-03-18 06:46:25 ET Summary I have been actively reshaping my portfolio by selling off low-conviction holdings and focusing on high-growth compounders. I have reduced my holdings from roughly 90 to roughly 70 over the past 6 months or so. I am excited about my current alloc...
2024-03-17 10:01:39 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...
2024-03-15 12:40:36 ET More on UnitedHealth Shares Steady, Growth Persists. Upgrading UnitedHealth To A Buy UnitedHealth Group: Doubling Down On This Dividend Growth Machine UnitedHealth: Rejoice When The Market Turns Fearful (Upgrade) Option Care warns of fi...
2024-03-15 01:44:56 ET Summary I focus on dividend growth stocks as a strategy for long-term outperformance and financial freedom. I compare three new dividend-paying stocks (Meta Platforms, Booking Holdings, and Salesforce) to their high-conviction dividend growth stocks. I e...
Acquisition to enhance capabilities in multi-site infusion services, specialty pharmacy Elevance Health (NYSE: ELV) today announced the closing of its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies. P...
2024-03-07 01:03:20 ET Summary Elevance Health showcased strong financial growth in Q4 and the full year of 2023, highlighting increased revenues and earnings per share. Technical analysis indicates a bullish trend, with the stock price currently preparing for a potential rally. ...
2024-03-07 01:03:20 ET Summary Elevance Health showcased strong financial growth in Q4 and the full year of 2023, highlighting increased revenues and earnings per share. Technical analysis indicates a bullish trend, with the stock price currently preparing for a potential rally. ...
2024-03-06 11:45:18 ET More on Humana, UnitedHealth, etc. Humana: Solid Growth Prospects Despite Cost Challenges Shares Steady, Growth Persists. Upgrading UnitedHealth To A Buy UnitedHealth Group: Doubling Down On This Dividend Growth Machine Hospital group s...
News, Short Squeeze, Breakout and More Instantly...
Elevance Health Inc Com Company Name:
ELV Stock Symbol:
NYSE Market:
Elevance Health Inc Com Website:
2024-07-17 12:00:27 ET Image source: The Motley Fool. Elevance Health (NYSE: ELV) Q2 2024 Earnings Call Jul 17, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Elevance Health (ELV) Q2 2024 Earnings Call Transcript
Assa Abloy AB ADR (ASAZY) is expected to report for Q2 2024 First Horizon Corporation (FHN) is expected to report $0.37 for Q2 2024 Community Trust Bancorp Inc. (CTBI) is expected to report $1.03 for Q2 2024 Cohen & Steers Inc (CNS) is expected to report for Q2 2024 First Indu...
2Q 2024 operating revenue of $43.2 billion 2Q 2024 adjusted operating gain 1 of $2.8 billion 2Q 2024 diluted EPS 2 of $9.85, up 26%; adjusted diluted EPS 1 of $10.12, up 12% 3Q 2024 dividend of $1.63 per share declared to shareholders Elevance Healt...